查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620378

全球鮭魚降鈣素市場：按產品類型、分銷管道、地區、範圍和預測

Global Calcitonin Salmon Market By Product Type, By Distribution Channel, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

鮭魚降鈣素市場規模及預測

過去幾年，鮭魚降鈣素市場規模一直在快速成長，成長率顯著，預計該市場在預測期內（即 2024-2031 年）將顯著成長。

全球鮭魚降鈣素市場是由全球骨質疏鬆症患者數量不斷增加所推動的。根據國際骨質疏鬆基金會統計，全球每年有超過 890 萬人患有骨質疏鬆症。全球鮭魚降鈣素市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球鮭魚降鈣素市場定義

降鈣素，也稱為甲狀腺降鈣素，是一種由人類甲狀腺濾泡旁細胞產生的線性多□激素。在鳥類、魚類和其他非哺乳動物中，降鈣素是由胰管中的細胞產生的。降鈣素降低血液中鈣和磷酸鹽的濃度，促進骨形成。降鈣素抑制稱為破骨細胞的去骨細胞，同時促進稱為成骨細胞的骨形成細胞。與哺乳動物來源的降鈣素相比，每毫克鮭魚降鈣素的效力更大，作用持續時間更長。

鮭魚降鈣素是利用重組DNA技術透過合成方法或微生物方法生產的。鮭魚降鈣素有兩種劑型：注射劑和鼻噴劑。 Fortical 和密鈣星是鮭魚降鈣素的常見品牌。鮭魚降鈣素用於治療骨質疏鬆症、高血鈣症、佩吉特骨病變和其他骨骼相關疾病。

鮭魚降鈣素的世界市場概況

全球鮭魚降鈣素市場是由全球骨質疏鬆症患者數量不斷增加所推動的。根據國際骨質疏鬆基金會統計，全球每年有超過 890 萬人患有骨質疏鬆症。骨質疏鬆症在女性中比男性更常見，並且在老年族群中更常見。根據國際骨質疏鬆基金會的研究，全球有超過2億名女性受到骨質疏鬆症的影響。 FDA 諮詢委員會建議不要使用鮭魚降鈣素來治療女性經後骨質疏鬆症，因為有罹患癌症的風險。

此外，鮭魚降鈣素也被用作骨質疏鬆症的二線治療藥物。鮭魚降鈣素的副作用可能是全球市場的主要阻礙因素。此外，佩吉特氏症並不是一種常見疾病。這些因素阻礙了鮭魚降鈣素市場的成長。作為骨質疏鬆症和相關疾病一線治療藥物的其他藥物的現成供應可能會限制市場。 FDA 諮詢委員會建議開發新鮭魚降鈣素產品的公司證明其在減少骨折方面的有效性。預計將提振市場。

世界人口老化是骨質疏鬆症發生率上升的主要原因。骨質疏鬆症因其在世界範圍內的高盛行率而被報告為一個嚴重的公共衛生問題。據估計，目前全球有超過2億人患有骨質疏鬆症。此外，隨著鮭魚降鈣素被批准作為停經後患者的預防和其他治療藥物，預計未來需求將會增加。農村地區對骨質疏鬆症和其他骨骼疾病缺乏認識阻礙了鮭魚降鈣素市場的成長。

此外，長期使用的副作用正在阻礙鮭魚降鈣素市場的成長。人類使用藥物委員會建議，鮭魚降鈣素應服用兩週，最多四週，以預防因突然不動而造成的急性骨質流失。

目錄

第一章全球鮭魚降鈣素市場介紹

  • 市場概覽
  • 調查範圍
  • 先決條件

第 2 章執行摘要

第三章驗證市場研究研究方法

  • 資料探勘
  • 驗證
  • 初步面試
  • 資料來源列表

第四章世界鮭魚降鈣素市場前景

  • 摘要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力模型
  • 價值鏈分析

第五章全球鮭魚降鈣素市場：依產品類型

  • 摘要
  • 鮭魚降鈣素鼻噴劑
  • 鮭魚降鈣素注射液

第 6 章鮭魚降鈣素的全球市場：依通路劃分

  • 摘要
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 7 章鮭魚降鈣素的全球市場：按地區劃分

  • 摘要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東

第八章全球鮭魚降鈣素市場競爭格局

  • 摘要
  • 各公司的市場排名
  • 主要發展策略

第九章公司簡介

  • Novartis
  • Sanofi
  • Mylan Pharmaceuticals
  • Apotex
  • Upsher-Smith Laboratories
  • Ferring Pharmaceuticals
  • Par Pharmaceutical
  • Torrent
  • Sun Pharmaceutical
  • Shanghai Soho-Yiming Pharmaceuticals

第 10 章附錄

  • 相關研究
簡介目錄
Product Code: 11842

Calcitonin Salmon Market Size And Forecast

Calcitonin Salmon Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2024 to 2031.

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. The Global Calcitonin Salmon Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Calcitonin Salmon Market Definition

Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In birds, fish, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg is greater and has longer duration of action than calcitonin produced by mammalian origin.

Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Fortical and Miacalcin are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Calcitonin Salmon Market Overview

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. Osteoporosis is more dominant in women than men and is common in geriatric population. The International Osteoporosis Foundation study reveals that over 200 million women are affected by osteoporosis globally. The FDA advisory committee has recommended preventing use of calcitonin salmon for the treatment of postmenstrual osteoporosis in women as there exists a potential risk of cancer development.

Moreover, calcitonin salmon is used as second line of treatment for osteoporosis. Side effects of calcitonin salmon are likely to be key restraints of the global market. Large number of people is not aware about having osteoporosis until they have first fracture and also Paget's disease is not common in people. These factors hamper the growth of the Calcitonin Salmon Market. Easy availability of other medications for the first line treatment of osteoporosis and related diseases is likely to restrain the market. The FDA advisory committee has suggested to companies developing new calcitonin salmon products to prove its effectiveness in reducing bone fractures. This is expected to boost the market.

Aging of populations worldwide is the major reason for the rise in the incidence of osteoporosis. Osteoporosis is reported as a serious public health concern, owing to its high prevalence worldwide. At present, it is estimated that over 200 million people globally suffer from osteoporosis. In addition, calcitonin salmon's approval for the prevention of postmenopausal and other treatment to uplift the demand in growth in the future. Lack of awareness in rural areas about osteoporosis and other bone disorder is hindering the growth of Calcitonin Salmon Market.

Furthermore, adverse effects caused due to prolong use are hampering the growth of the Calcitonin Salmon Market. It has been found that prolonged use rises the risk for cancer, attributed to this Committee for Medicinal Products for Human Use recommended that calcitonin salmon should be prescribed for two weeks with a maximum duration of four weeks for prevention of acute bone loss due to sudden immobilization.

Global Calcitonin Salmon Market Segmentation Analysis

The Global Calcitonin Salmon Market is Segmented On The Basis Of Product Type, Distribution Channel, and Geography.

Calcitonin Salmon Market, By Product Type

  • Calcitonin Salmon Nasal Spray
  • Calcitonin Salmon Injection

Based on Product Type, the market is segmented into Calcitonin Salmon Nasal Spray, Calcitonin Salmon Injection. Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Miacalcin and Fortical are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

Calcitonin Salmon Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on Distribution Channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts.

Calcitonin Salmon Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, the Global Calcitonin Salmon Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Prevalence of osteoporosis is higher in Middle East & Africa than in countries in the West. This is expected to propel the Calcitonin Salmon Market in this region. Increasing geriatric population with bone related diseases is likely to fuel the growth of the market in Asia Pacific during the forecast period.

  • Key Players In Calcitonin Salmon Market
  • The "Global Calcitonin Salmon Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
  • Novartis, Sanofi, Mylan Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Ferring Pharmaceuticals, Par Pharmaceutical, Torrent, Sun Pharmaceutical, United Biotech (P) Limited. and Shanghai Soho-Yiming Pharmaceuticals.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • Global Calcitonin Salmon Market

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CALCITONIN SALMON MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CALCITONIN SALMON MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CALCITONIN SALMON MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Calcitonin Salmon Nasal Spray
  • 5.3 Calcitonin Salmon Injection

6 GLOBAL CALCITONIN SALMON MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
  • 6.2 Hospital Pharmacies
  • 6.3 Retail Pharmacies
  • 6.4 Online Pharmacies

7 GLOBAL CALCITONIN SALMON MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East

8 GLOBAL CALCITONIN SALMON MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Novartis
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Sanofi
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Mylan Pharmaceuticals
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Apotex
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Upsher-Smith Laboratories
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Ferring Pharmaceuticals
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Par Pharmaceutical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Torrent
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sun Pharmaceutical
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Shanghai Soho-Yiming Pharmaceuticals
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research